Stock screener

SGMT

Conviction 43HealthcareScan · Thu, Sep 24, 2026
Three outside down

Sagimet Biosciences Inc. (SGMT) closed at $9.11 (-12.57%) on Sep 24, 2026. Its latest daily candle is a three outside down. Price is below its 50-day and above its 200-day moving average. RSI(14) 37, RS Rating 92, -18.4% from its 52-week high, +52.1% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

SGMT$9.11-12.57%
ResistanceSupportVol 14Insider sell
63 bars
2
Vol MA14 1.38M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Sagimet Biosciences Inc.PHARMACEUTICAL PREPARATIONSwww.sagimet.com ↗
Price9.11
Change-12.57%
Gap-6.14%
Rel volume7.02×
Avg volume1.24M
Avg $ vol12.89M
SMA 2010.70
SMA 509.48
SMA 2007.08
Price vs 50-3.94%
Price vs 200+28.75%
MA stackmixed
50/200 cross—
Supertrenddown · 11.52
RSI (14)37
MACD hist-0.21
MACD cross—
Stoch %K / %D16 / 35
ADX (14)38
+DI / −DI18 / 29
RSI divergenceBearish
MACD divergenceBearish
ATR %7.49%
ADR %5.50%
52w high11.17
52w low4.55
From 52w high-18.44%
Above 52w low+100.22%
New 52w highNo
SqueezeFired
Bollinger width16.57%
%B-0.39
Donchian pos15.53%
Donchian high11.45
Donchian low8.68
AVWAP (52w high)10.20
vs AVWAP high-10.66%
AVWAP (52w low)8.23
vs AVWAP low+10.65%
OBV trendDown
Chaikin MF (20)-0.11
Today vs 20d7.02×
Avg vol (14d)1.38M
Avg vol (20d)1.24M
Avg $ vol (20d)12.89M
Market cap279.45M
RS Rating92 / 99
RS 3m (vs SPY)+28.31%
RS 6m (vs SPY)+80.37%
RS line new highNo
Trend template7/8
Technical rank66.0
1 week-18.44%
1 month-11.47%
3 months+32.80%
6 months+97.19%
1 year+35.36%
YTD+52.09%
P/E-5.48
P/B1.09
P/S139.72
P/FCF—
EPS-1.58
Div yield—
ROE-19.92%
ROA-19.37%
Debt/Eq—
Current45.02
EV/EBITDA—
Gross margin—
Net margin—
Rev growth0.00%
EPS growth-12.01%
Price target28.11
Target upside208.56%
Analyst ratingBuy
Institutional84.88%
Ent. value113.55M
Revenue2M
Net income-13.95M
Gross profit—
Free cash flow—
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out32.02M
Employees16
ListedFri, Jul 14, 2023
Free float28.28M
Float %91.2%
Short interest10.11M
Days to cover9.6d
Short volume54.4%
Squeeze score90 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.26 vs −$0.28
Last surprise+7.1% beat
Setup gradeD
Conviction43 / 100
Pattern quality—
Tech rank66.0 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmThree outside down

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SGMT

All disclosures →
No recent disclosed trades by Congress in SGMT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SGMT · open-market 2 sells

InsiderSideShares
Kemble George
Director · Series A Common Stock · 2026-08-14
Exercise326.62K
Kemble George
Director · Series A Common Stock · 2026-08-14
Exercise24.37K
Kemble George
Director · Series A Common Stock · 2026-08-14
Sell350.99K
Kemble George
Director · Stock Option (Right to Buy) · 2026-08-14
Exercise326.62K
Kemble George
Director · Stock Option (Right to Buy) · 2026-08-14
Exercise24.37K
Kemble George
Director · Series A Common Stock · 2026-08-11
Exercise9.75K
Kemble George
Director · Series A Common Stock · 2026-08-11
Exercise10.46K
Kemble George
Director · Series A Common Stock · 2026-08-11
Sell20.21K
Kemble George
Director · Stock Option (Right to Buy) · 2026-08-11
Exercise9.75K
Kemble George
Director · Stock Option (Right to Buy) · 2026-08-11
Exercise10.46K

SEC filings

EDGAR filings in SGMT · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.